Dr. Cameron Clokie is an oral & maxillofacial surgeon, serial entrepreneur and a scientist. He is also the Chief Executive Officer at Induce Biologics Inc., a regenerative medication organization concentrated on technological solutions dealing with musculoskeletal rebuilding. In a span of three decades, he engaged in scholarly dentistry and clinical practice, and most presently, he has been referred as the Chief of Oral & Maxillofacial Surgery within 1998. He is also the Professor of Oral & Maxillofacial Surgery at Toronto University until he retired from scholastics in 2017. He has likewise held positions on scientific advisory boards and other general boards of various organizations.
Cameron Clokie has made numerous presentations and published different papers both broadly and globally on regenerative medicine and bone reconstruction. As a holder of 25 USA and worldwide existing as well as pending licenses, including those associated with bone recuperating, he has possessed the capacity to effectively establish key alliances together with organizations and exchange his impressive learning and creativity into business viable firms.
He has added to numerous distributions and has lectured globally on an assortment of themes identified with university-associated technology transfer and oral regeneration. Within 1993, Cameron set up a bone research team based at McGill University before it was later shifted to the University of Toronto in 1998. The group on Bloomberg has been effectively engaged in the assessment and advancement of new bone regenerative innovations.
The major objective of his work is to create bioimplants that will in the long run substitute the requirement for autogenous bone grafts. Cameron Clokie got his Doctor of Dental Surgery – DDS in 1985 and finished his specialty training in year 1990. Because of his creative ways to deal with the surgical administration of the jaws he is commonly referred as a clinician and educator. Dr. Clokie has numerous productions and has addressed universally on an assortment of subjects under oral human services including the fate of Dentistry, bone recovery, Oral and Maxillofacial Surgery, and University associated technology transfer. He likewise works at GenSci Regeneration Sciences Inc. as Scientific consultant and before he has been given licenses for technologies established within his laboratory both for Europe and North America.